Infectious Disease

Top Story

Researchers develop portable Zika test

Researchers develop portable Zika test
February 26, 2017

Researchers at Florida Atlantic University are developing a portable diagnostic tool that can work in a range of settings to accurately detect Zika virus within 15 minutes using just a saliva sample, according to a press release. They said a single test would cost approximately $2.

“Most of the Zika cases in the United States and especially Florida are travel-related,” Waseem Asghar, PhD, assistant professor in the departments of computer and electrical engineering, computer science, and biological sciences at Florida Atlantic University, said in the release. “We are working to develop a tool that can be used without expensive laboratory equipment and skilled technicians in various settings like an airport or a community health center to provide reassurance to expectant families and those concerned because of recent travel.”

$17.6 million grant supports development of global vaccine manufacturing platform

February 25, 2017
The Bill & Melinda Gates Foundation awarded a $17.6 million grant to researchers at the Massachusetts Institute of Technology, University College London and…

Viral outbreak linked to rats spreads to nine US states, Canada

February 24, 2017
An outbreak of the rodent-borne Seoul virus that was initially reported in Illinois and Wisconsin is suspected to have spread to at least seven other U.S. states…
FDA News

FDA clears two tests used to assist treatment decisions for infections, sepsis

February 24, 2017
The FDA recently approved the expanded use of the Vidas Brahms PCT Assay, which guides antibiotic treatment decisions for patients with lower respiratory tract…

Merck announces Zepatier coverage by Ontario, British Columbia

February 24, 2017
Ontario will become the first Canadian province to reimburse for Zepatier in the treatment of chronic hepatitis C, effective Feb. 28, 2017, followed by British Columbia…
More News Headlines »
CME

Rapid Response from Barcelona: New Data in HCV Treatment

This activity is supported by an educational grant from AbbVie and Merck & Co., Inc.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Abstract OnlyIn the Journals Plus

Hospital clones of methicillin-resistant Staphylococcus aureus are carried by medical students even before healthcare exposure

February 26, 2017
AUTHORS:
Orlin I, et al.
More »
Featured
Conference on Retroviruses and Opportunistic Infections (CROI)

Conference on Retroviruses and Opportunistic Infections (CROI)

Video
Meeting News

VIDEO: Cost to treat HCV could be as low as $80 in the US

November 18, 2016
More »
Advertisement
Advertisement